Health economics and health technology assessment specialists

Delivering
Excellence

We combine strategic, analytic and communications excellence to optimally demonstrate your product’s value throughout its lifecycle.

Case studies

World-class
Expertise

Choosing Visible Analytics gives you access to world-class technical and strategic expertise, whatever your project.

Our team

Personal
Service

Our approach is based on partnership, scientific excellence and personal service – with our Directors closely involved in every project.

Our approach

Building bridges from data to decisions

Optimising value throughout the product lifecycle

We can work with you from early modelling and value propositions, through evidence generation, statistical and real-world data analysis, economic modelling, health technology assessment submission and value communication.

We work with clients across Europe, North America and Asia-Pacific on global, regional and local-level projects.

Our systematic reviews are conducted in accordance with internationally recognised guidelines and meet the standards of HTA bodies. We have specialist expertise in evidence synthesis and provide resourceful, innovative solutions based on data availability and jurisdiction requirements. 

Find out more

Our statistical team are experts in the full range of analyses required to inform economic evaluations, as well as in evidence synthesis and design and analysis of clinical trials, observational studies and real-world evidence datasets. We can also advise on the strategic implications of different analytical approaches for HTA. 

Find out more

We are experts in modelling for every stage of your product’s life cycle, including early decision-making models, pricing models, cost-effectiveness and budget impact models, and interactive payer-facing modelling tools. 

Find out more

We can help identify the most robust real-world data for your needs and design studies to inform clinical strategy, enhance market access and support regulatory submissions.  

Find out more

Our first-class strategic, technical and communications expertise makes us outstanding partners for your HTA submissions. 

Find out more

We combine our deep understanding of payer evidence requirements with our communications expertise to develop materials that demonstrate value to payers, clinicians and decision-makers.

Find out more

Case studies

Diagnostic device HTA assessment – from secondary to primary care

Diagnostic device HTA assessment – from secondary to primary care

Develop the economic assessment and the submission dossier

Read More
Joint modelling of survival data

Joint modelling of survival data

Predict the survival time of patients with solid tumours in an oncology treatment trial using longitudinal data on sum of diameters of target lesions

Read More
Component network meta-analysis of combination treatments for a blood cancer

Component network meta-analysis of combination treatments for a blood cancer

Estimate the comparative effectiveness of new blood cancer treatment given complex evidence base: disconnected network of RCTs and multiple treatment combinations evaluated

Read More
Optimisation of a payer value story to showcase the benefit of a treatment

Optimisation of a payer value story to showcase the benefit of a treatment

Review and revise value messages and optimise cost-effectiveness model

Read More
Collaborative support for market access

Collaborative support for market access

Develop a comprehensive market access strategy, including evidence generation and value messaging, to support HTA and reimbursement submissions

Read More
Indirect treatment comparison accounting for the differently timed scheduled assessments

Indirect treatment comparison accounting for the differently timed scheduled assessments

Perform an ITC accounting for the differently timed scheduled assessments between the index and comparator trials

Read More
Interactive and user-friendly pricing tool in RShiny

Interactive and user-friendly pricing tool in RShiny

Develop a flexible, interactive and user-friendly pricing model tool

Read More
Indirect comparison incorporating Real-World Evidence

Indirect comparison incorporating Real-World Evidence

Estimate survival advantage compared to current clinical practice as per HTA requirements

Read More
 

What our clients say

Very high-quality discussions and deliverables, building a fast trustworthy working relationship and always on time.

Global HEOR Director  | Top Global Medical Device Company

It hasn’t been an easy journey and your support and advice on both technical and strategic matters have been crucial to get to this point.”

Market Access and Reimbursement  | Top 5 Global Pharmaceutical Company

News & insights

VA Webinar, Use of Real-World Evidence in HTA

VA Webinar, Use of Real-World Evidence in HTA

Join us for an engaging webinar to explore the transformative power of RWE in HTA and how it’s driving better healthcare decisions and patient outcomes.
ISPOR Europe 2024 17-20 November

ISPOR Europe 2024 17-20 November

The Visible Analytics team will be in Barcelona and looks forward to meeting you there.
Come meet us at our booth 1506 and join us at one of our sessions.

VA Webinar, February 14th 2024 HTA methods to optimize evidence generation plans

VA Webinar, February 14th 2024 HTA methods to optimize evidence generation plans

Visible Analytics will be co-hosting a live webinar with Ascenian to discuss how HTA methods and early value assessment can help companies prepare for evidence generation and early market access strategy.